2008
- Domestic AIDS Epidemic Ignored at Republican National Convention: Advocates call on John McCain to commit to develop a National AIDS Strategy for the U.S.
- PRNewswire - September 5, 2008
- MINNEAPOLIS and ST. PAUL, Minn., Sep. 5 /PRNewswire-USNewswire/ -- The Republican National Convention concluded last night with no mention of the domestic AIDS epidemic in the United States and only passing reference to the epidemic overseas. Neither Presidential nominee Sen. John McCain nor Vice Presidential nominee G
- The HealthCentral Network Acquires TheBody.com, the Number One Interactive Resource for HIV Communities
- PRNewswire - September 4, 2008
- -- Site brings highest quality, largest audiences of patients concerned about HIV prevention and treatment, and a unique connection with HIV-focused physicians ARLINGTON, Va., Sept. 4 /PRNewswire/ -- The HealthCentral Network, Inc. (www.HealthCentral.com) today announced the acquisition of HIV/AIDS patient resource The
- Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
- PRNewswire - September 4, 2008
- -- 100 mg cohort demonstrates potent antiviral activity and favorable safety profile CAMBRIDGE, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious disease
- More than 1,000 Journalists Enlisted in Fight Against HIV/AIDS
- PRNewswire - September 4, 2008
- WASHINGTON, Sept. 4 /PRNewswire/ -- In some countries, lime juice is thought to ward off HIV/AIDS. In others, homosexuality is not publicly discussed. Against such a backdrop of misinformation and stigma, how can developing countries fight a virus that has already killed tens of millions of people? Part of the answer i
- FDA Approves First Hepatitis B Viral Load Test
- PRNewswire - September 4, 2008
- -- Another Roche first in TaqMan(R) real-time PCR testing for the diagnostic lab PLEASANTON, Calif., Sept. 4 /PRNewswire/ -- The U.S. Food & Drug Administration ( FDA ) has approved the Roche COBAS(R) TaqMan(R) HBV Test, the first assay for quantitating Hepatitis B Virus DNA approved in the U.S. The test uses Roche
- Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees
- PRNewswire - September 2, 2008
- -- Delegates Join World Vision, ONE to Build Hope and Give Help MINNEAPOLIS, Sept. 2 /PRNewswire-USNewswire/ -- Delegates to the Republican Party Convention are sending a message to the most vulnerable communities around the world including evacuees in the Gulf Coast region and those suffering from HIV and AIDS in deve
- InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
- PRNewswire - September 2, 2008
- -- $15 million development milestone payment to InterMune -- Roche to lead ITMN-191 program in Phase 2 BRISBANE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- InterMune, Inc. (NASDAQ:ITMN) today announced that InterMune has earned a $15 million development milestone under its development collaboration with Roche for the he
- The Female Health Company Receives Order for 4.3 Million FC2 Female Condoms for Papua New Guinea
- PRNewswire - September 2, 2008
- CHICAGO, Sept. 2 /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) which manufactures and markets the FC and FC2 Female Condoms(R), today announced it has received an order for 4.3 million FC2s from the Papua New Guinea - Australia HIV and AIDS program.
- PhRMA Members Lead the World in Cancer Research Investment
- PRNewswire - September 2, 2008
- WASHINGTON, Sept. 2 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) applauds the leadership of television news anchors Katie Couric, Charles Gibson and Brian Williams and the commitment of their respective networks in donating one hour of primetime programming on Sept. 5 to S
- AIDS Responsibility Project Invites You to Join Us for a Panel Discussion During the RNC Convention: After the Welfare State, and After the Katrina Disaster
- PRNewswire - August 31, 2008
- -- How Social Entrepreneurs and Corporations are Bringing Business Solutions To solve our Nation s Public Policy Challenges MINNEAPOLIS, Aug. 31 /PRNewswire-USNewswire/ -- Monday, September 1, 2008 -- Marquette Hotel, 710 Marquette Ave -- Lunch will be served, Program Begins at 12:30PM Few policy leaders would defend t
- Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania
- PRNewswire - August 29, 2008
- -- Joint Effort with Baylor International Pediatric AIDS Initiative Will Improve Access to Health Care for Children with HIV/AIDS WASHINGTON, Aug. 29 /PRNewswire-FirstCall/ -- The Abbott Fund joined representatives from the U.S. government, Baylor College of Medicine, the government of Tanzania and other part
- Bill Clinton and Other Leaders Call For 'Renewal of Battle Against AIDS' in the United States at Democratic Convention: Advocates disappointed that Obama failed to address the issue
- PRNewswire - August 29, 2008
- DENVER, Aug. 29 /PRNewswire-USNewswire/ -- Speaking at the Democratic National Convention Wednesday night, Former President Bill Clinton called for a reinvigorated response to the domestic HIV/AIDS epidemic in the United States . In praising Presidential nominee Barack Obama, Clinton said, He will continue and enhance
- Bristol-Myers Squibb Welcomes NICE Guidance Recommending Baraclude(R) (entecavir) as a Treatment Option for Chronic Hepatitis B
- PRNewswire - August 29, 2008
- UXBRIDGE, England, August 29/PRNewswire/ -- NICE (National Institute for Health and Clinical Excellence) has published guidance that recommends Baraclude(R) (entecavir) as an option for treatment of eligible patients with chronic hepatitis B (CHB). Entecavir is a potent anti-viral treatment for chronic Hepatitis B that
- INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy
- PRNewswire - August 29, 2008
- -- INTELENCE is the First NNRTI to Show Antiviral Activity in Patients With NNRTI-Resistant Virus CORK, Ireland , August 29/PRNewswire/ -- The European Medicines Agency (EMEA) has granted marketing authorisation for the anti-HIV medication INTELENCE(TM) (etravirine). INTELENCE is a next generation non-nucleoside revers
- Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes
- PRNewswire - August 29, 2008
- Four-month study detailing effects of treatment of HIV-positive individuals with American Biotech Labs (ABL) ASAP 10 treatment indicates significant improvement in the condition of the subjects after treatment; in-vitro laboratory work shows that ABL nanosilver particles can block entry of the virus into cells, eventua
- Convicted Medicare Fraud Defendant Pleads Guilty to Laundering More Than $3 Million in Fraudulent Proceeds
- PRNewswire - August 29, 2008
- WASHINGTON, Aug. 29 /PRNewswire-USNewswire/ -- Miami resident Juan Carlos Castaneda, 47, pleaded guilty today to participating in a conspiracy to launder approximately $3.8 million in proceeds from several Medicare fraud schemes, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U.S. Atto
- New Research Reveals That Mycamine(R) is an Effective Treatment in Children, Young Babies and Premature Infants
- PRNewswire - August 28, 2008
- -- Research Adds to Already Demonstrated Efficacy in Adult Population -- Not for distribution in the United Kingdom STAINES, England, August 28/PRNewswire/ -- Parents and paediatricians are today welcoming the results of new research that adds additional support for an effective and well tolerated treatment for childre
- Panic At The Disco and Plain White T's to Take the Stage at the Rock Band 2 Party to Benefit LIFEbeat Saturday, September 6th at House of Blues in Los Angeles
- PRNewswire - August 28, 2008
- NEW YORK, Aug. 28 /PRNewswire/ -- Rock Band 2 -- the next incarnation of the cultural and video game phenomenon Rock Band -- is teaming up with LIFEbeat to shed some star power over the continued need for HIV/AIDS prevention in the week prior to the game s launch. On Saturday, September 6th at House of Blues in Los Ang
- AIDS Crisis in Communities of Color Prompts Demand for National Plan to Fight HIV/AIDS
- PRNewswire - August 27, 2008
- -- Public Health Advocates Deliver Demand during the Democratic National Convention Calling on Senators Barack Obama and John McCain to Support a Comprehensive National AIDS Strategy LOS ANGELES, Aug. 27 /PRNewswire-USNewswire/ -- In a historically unprecedented move, over 30 national HIV/AIDS organizations and leaders
- Daschle, Convention Delegates, Daughtry Join to Give Help to AIDS-Affected People Around the World
- PRNewswire - August 26, 2008
- -- Delegates Join World Vision, ONE to Build Hope, Give Help Around the World DENVER, Aug. 26 /PRNewswire-USNewswire/ -- Delegates to the Democratic Party Convention are sending a message to people suffering from HIV and AIDS around the world: We want to help. Doing something unconventional at the party s presidential
- Half of Surveyed Physicians Expect to Replace Between 6 Percent and 15 Percent of Their Sustiva Prescriptions with Isentress: Most Surveyed MCO Pharmacy Directors Do Not Place Cost Control Measures on Branded Antiretroviral Drugs, According to a New Report from Decision Resources
- PRNewswire - August 26, 2008
- WALTHAM, Mass., Aug. 26 /PRNewswire/ -- Decision Resources, one of the world s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the expansion of labeling for Merck s Isentress to include use in treatment naive patients will significantly impact sales of the drug for HIV treatment
- Here's Hope and the AIDS Epidemic in the South
- PRNewswire - August 25, 2008
- -- I was working in Miami, renting a room, and getting by alone. Then my body started breaking down. Because of my weak HIV-positive system, my diabetes and my hypertension kicked up and I couldn t work. I couldn t make rent, so I ended up homeless. The South Florida AIDS Network led me to Here s Hope and that s where
- Congressional Leadership Awards at DNC Honor Commitment to Fight HIV/AIDS
- PRNewswire - August 25, 2008
- -- Calls for Congressional Candidates to Support National AIDS Strategy DENVER, Aug. 25 /PRNewswire-USNewswire/ -- Today, Spreading Hope: Congressional Leadership Awards in the Fight Against HIV/AIDS luncheon occurs during the Democratic National Convention at the Hotel Monaco
- Democrats to be Recognized in Denver for Leadership on HIV/AIDS
- PRNewswire - August 25, 2008
- -- All Candidates for Congress Asked to Sign Pledge on AIDS and Poverty DENVER, Aug. 25 /PRNewswire-USNewswire/ -- In a luncheon today in Denver, two leading AIDS organizations are recognizing Democratic members of Congress who have shown extraordinary leadership in the fight against HIV/AIDS, both in the US and around
- WashingtonWatch.com Weekly Update: Senator Biden's Priorities
- PRNewswire - August 25, 2008
- WASHINGTON, Aug. 25 /PRNewswire-USNewswire/ -- This is the WashingtonWatch.com federal legislative update for the week of August 25, 2008. Congress continues its August recess and will not return to Washington for a couple more weeks. This week, the Democratic party convention in Denver will complete the process of sel
- AltaMed Opens First-of-its-Kind Health Care Center in the Nation: 32,000 Sq. Ft. Facility Helps Tackle Health Care Crisis by Providing Sorely Needed Medical, Dental and Senior Services to Critically Underserved Area of Los Angeles County
- PRNewswire - August 22, 2008
- LOS ANGELES, Aug. 22 /PRNewswire/ -- AltaMed Health Services along with community and political leaders, celebrated today the grand opening of the Family Health and Wellness Center located in the heart of El Monte. With a population in critical need of health care services, the Family Health and Wellness Center represe
- Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000: 9,395 Women Enrolled in Trial Sponsored by Medical Research Council
- PRNewswire - August 22, 2008
- LEXINGTON, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (NASDAQ:IDEV) announced today the completion of enrollment in Protocol MDP 301, a Phase III clinical trial of PRO 2000, the Company s candidate vaginal microbicide for the prevention of HIV and other sexually transmitted infections. The t
- Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc.: Licensee of Blue Cross/Blue Shield in fourteen states establishes guidelines for use of Trofile
- PRNewswire - August 20, 2008
- SOUTH SAN FRANCISCO, Calif., Aug. 20 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced that Wellpoint, Inc. has established a national Medical Policy Guideline for Monogram s Trofile Assay. Wellpoint s guidelines provide that HIV tropism testing with Trofile is considered medically nec
- TheraQuest Presents Topical Local Anesthetic and Abuse Deterrence Data at the World Congress on Pain
- PRNewswire - August 20, 2008
- BLUE BELL, Pa., Aug. 20 /PRNewswire/ -- TheraQuest Biosciences, Inc. a development stage pain management company is presenting data today on TQ-1019, its proprietary topical local anesthetic and on SECUREL(R), its abuse deterrent technology at the World Congress on Pain in Glasgow, Scotland. TheraQuest will present fou
- Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV: Collaboration Will Seek to Identify microRNAs Implicated in HIV Viral Replication and Their Function
- PRNewswire - August 20, 2008
- -- Samples Will be Screened and Analyzed Using Rosetta Genomics Proprietary microRNA Technologies REHOVOT, Israel and JERSEY CITY, New Jersey, August 20 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today a collaboration with the National Institute of Health to identify microRNAs involved in
- New HIV Prevention/Anti-Stigma Campaign Featuring HIV Positive & Negative Persons 'TOGETHER' Launches Across the Nation
- PRNewswire - August 19, 2008
- SAN FRANCISCO, Aug. 19 /PRNewswire/ -- TOGETHER ... HIV STOPS WITH US is the message of the new media campaign launching today in areas across the country including: Boston, Long Beach and Alameda County, CA. Billboards, transit ads, posters featuring real HIV positive people, and a wide spectrum of HIV negative person
- Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
- PRNewswire - August 19, 2008
- SAN DIEGO, Aug. 19 /PRNewswire-FirstCall/ -- Vical Incorporated (NASDAQ:VICL) today announced a research collaboration with the Karolinska Institute, a leading European medical university, and the Swedish Institute for Infectious Disease Control (SMI), a governmental expert agency, to evaluate Vical s Vaxfectin(R) adju
- Tobira Therapeutics Inc. Receives US Patent for TBR-652: Clinical trial currently in Phase I
- PRNewswire - August 18, 2008
- PRINCETON, N.J. and SAN DIEGO, Aug. 18 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the issuance of Patent No. 7,371,772 B2 by the U.S. Patent and Trademark
- Aureus Pharma Releases New Unified Knowledge Database: AurSCOPE(R) Global Pharmacology Space and Drug Target Knowledge Databases Related to Nuclear Receptors and Proteases
- PRNewswire - August 18, 2008
- PARIS, August 18/PRNewswire/ -- Aureus Pharma, a leading provider of knowledge management solutions that accelerate life sciences discovery, announced today the release of three new AurSCOPE(R) Target knowledge databases. The new offerings include knowledge databases for the important drug targets Nuclear Receptor and
- Diplomat Specialty Pharmacy Partners With NeedyMeds.com to Increase Drug Access
- PRNewswire - August 18, 2008
- SWARTZ CREEK, Mich., Aug. 18 /PRNewswire/ -- Diplomat Specialty Pharmacy announced today that they have entered into a corporate agreement with NeedyMeds.com, an online data base listings of available financial assistance programs for patients requiring support with drug access. The mission of Diplomat s dedicated fund
- The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008
- PRNewswire - August 18, 2008
- -- Quarterly Reports use Market Intelligence and Competitive Analysis from Thomson Reuters to Explore Various Aspects of the Pharmaceutical Pipeline LONDON and PHILADELPHIA, Aug. 18 /PRNewswire/ -- Thomson Reuters, the world s leading source of intelligent information for businesses and professionals, has announced the
- Ardea Biosciences Announces Progress of Clinical Development Programs and Reports Second Quarter and Year-to-Date 2008 Financial Results
- PRNewswire - August 14, 2008
- SAN DIEGO, Aug. 14 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA), a company focused on the discovery and development of small-molecule therapeutics for the treatment of human immunodeficiency virus (HIV), gout, cancer and inflammatory diseases today reported recent accomplishments and financial result
- Nasal Hepatitis B Vaccine Elicits Robust Immunity With a Single Dose; Confers Major Advantages Over Traditional Vaccines: Study reported in August issue of journal PLoS One
- PRNewswire - August 13, 2008
- ANN ARBOR, Mich., Aug. 13 /PRNewswire/ -- A new study has shown that a nasal hepatitis B vaccine elicits a dramatic immune response in animals without requiring three vaccinations, sterile syringes or refrigeration-three factors that impede the delivery of current hepatitis B vaccines. In the study, a single dose of th
- FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay - Test Cleared to Screen Donated Blood for Hepatitis B, as well as HIV-1 and Hepatitis C, on Fully and Semi-Automated Instrument Systems
- PRNewswire - August 13, 2008
- SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the US Food and Drug Administration ( FDA ) has approved its supplemental regulatory application to use the PROCLEIX(R) ULTRIO(R) assay to screen donated blood for the hepatitis B virus (HBV). The FDA had previously
- National Healthcare for Homeless Day: August 13th, 2008: St. Anthony's Battles Highest Rate of TB Infection in U.S.
- PRNewswire - August 12, 2008
- SAN FRANCISCO, Aug. 12 /PRNewswire/ -- San Francisco has the highest rate of tuberculosis (TB) in the U.S., with recurrent outbreaks among the homeless and marginally housed, according to the most recent study on homelessness and TB by Harvard Medical School. Additionally, the Tenderloin has the highest rates of TB in
- GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
- PRNewswire - August 11, 2008
- ATLANTA, Aug. 11 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta-based, biopharmaceutical firm (the Company), developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its financial results and provided an operation
- Moujan Vahdat Opens Community United Empowerment Pavilion: The Grand Opening Of A New Housing Facility Aims To Improve The Lives Of New Yorkers Living With HIV/AIDS
- PRNewswire - August 11, 2008
- NEW YORK, Aug. 11 /PRNewswire/ -- Each year thousands of New Yorkers are diagnosed with HIV/AIDS leaving them scared and uncertain as to what their future holds. That unfortunate reality prompted New York real estate magnate Moujan Vahdat, one of the largest landowners in New York, to lend a hand by funding a housing f
- Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
- PRNewswire - August 8, 2008
- WALTHAM, Mass., Aug. 8 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, is featuring its new TB diagnostic test, the Clearview TB ELISA, at the International AIDS conference (AIDS 2008). The test, which
- Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule
- PRNewswire - August 7, 2008
- -- Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis of Request for Priority Regulatory Review MEXICO CITY, Aug. 7 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) presented pivotal data at the XVII International AIDS Conference (AIDS 2008) in Mexico City today showing that its investigational Norvir(R) (
- Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
- PRNewswire - August 7, 2008
- MEXICO CITY and SAN DIEGO, Aug. 7 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced that data was presented from its completed Phase 2a proof-of-concept monotherapy study of RDEA806, the Company s novel investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for patients wit
- Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads
- PRNewswire - August 7, 2008
- MEXICO CITY, Aug. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) announced that a retrospective analysis of six clinical trials found that anti-HIV regimens containing EPZICOM ( abacavir + lamivudine) were effective in treatment-naive patients regardless of baseline viral loads.
- Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients
- PRNewswire - August 7, 2008
- MEXICO CITY, Aug. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) today announced that 96-week data from the HEAT study show that once-daily EPZICOM ( abacavir + lamivudine) provides comparable efficacy to once-daily Truvada (R) (
- Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
- PRNewswire - August 7, 2008
- WALTHAM, Mass., Aug. 7 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, has announced the introduction of its new 4th generation rapid HIV diagnostic test, the Determine HIV-1/2 Ag/Ab Combo, at the Inter
- Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
- PRNewswire - August 7, 2008
- MEXICO CITY, Aug. 7 /PRNewswire/ -- Thousands of AIDS activists gathered today for the first-ever international rally for human rights and HIV/AIDS, a key event of the XVII International AIDS Conference. The activists called on governments to ensure greater human rights protections for people living with HIV and those
- President and Mrs. Bush Visit USAID Programs in Thailand
- PRNewswire - August 7, 2008
- WASHINGTON, Aug. 7 /PRNewswire-USNewswire/ -- The President and First Lady traveled to Thailand to celebrate 175 years of U.S.-Thai relations and to discuss bilateral and regional issues with Prime Minister Samak. During their stay, the President visited an AIDS hospice supported by the U.S. Agency for International De
- Tracleer(R) (bosentan) Receives EU Approval for Treatment of Patients With Mildly Symptomatic Pulmonary Arterial Hypertension
- PRNewswire - August 6, 2008
- ALLSCHWIL and BASEL, Switzerland , August 6/PRNewswire/ -- Actelion Ltd (SWX: ATLN) announced today that Tracleer(R) (bosentan), a dual endothelin receptor antagonist, has been approved in the European Union for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (PAH WHO functional class
- Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
- PRNewswire - August 6, 2008
- MEXICO CITY, Aug. 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) (GSK) announced today that a review of data from over 14,600 patients in 54 clinical studies showed no increased risk of myocardial infarction associated with the anti-HIV medication abacavir. GSK conducted this review upon learning that the analy
- ImQuest Receives $6.4 M Five Year Award from NIH to Develop Long-Lasting Combination Topical Microbicides To Prevent HIV Transmission
- PRNewswire - August 6, 2008
- FREDERICK, Md., Aug. 6 /PRNewswire/ -- ImQuest BioSciences announced today the successful acquisition of funding from the National Institutes of Health to support the development of a long lasting, safe, and acceptable combination topical microbicide product. ImQuest and a consortium of microbicide researchers from fou
- Pastor Rick & Kay Warren Bring Together Leaders to Discuss Unification of Expertise to Stop HIV/AIDS: Saddleback Church Hosts International AIDS Conference Satellite Session on the Partnership of Government, Business & the Church
- PRNewswire - August 6, 2008
- MEXICO CITY, Aug. 6 /PRNewswire/ -- Kay Warren, HIV/AIDS advocate, author and executive director of the Saddleback HIV/AIDS Initiative, moderated a panel of Rwandan government and church leaders; business and medical experts; and Saddleback HIV/AIDS Initiative directors; along with her husband, Rick Warren, founding pa
- National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting: Standards emphasize measurement gaps and harmonization
- PRNewswire - August 5, 2008
- WASHINGTON, Aug. 5 /PRNewswire-USNewswire/ -- To fill gaps in assessing clinician performance that can promote higher quality health care, the National Quality Forum (NQF) has endorsed 67 clinician-level consensus standards relating to cancer care, infectious diseases, perioperative care, and care provided by thousands
- Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV - Report: Hundreds of Studies Show that Programs to Curb Unsafe Sex and Drug Use are Highly Effective, but Often Overlooked in Global AIDS Response
- PRNewswire - August 5, 2008
- MEXICO CITY, Aug. 5 /PRNewswire/ -- In a new report released today, an international panel of AIDS experts calls on global leaders to aggressively expand HIV prevention programs aimed at reducing high-risk behaviors, including unsafe sex and drug use. Citing hundreds of clinical trials and observational studies, the re
- Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City - "From the Ground Up: Building Comprehensive HIV/AIDS Care Programs in Resource-Limited Settings" Features Work of More Than 230 Global Health Experts
- PRNewswire - August 5, 2008
- MEXICO CITY, Aug. 5 /PRNewswire-USNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation, with support from the A Day in the Life of Africa Foundation/Tides Foundation, the U.S. Government, Harvard University and others, unveiled today a comprehensive guide to improving and expanding HIV/AIDS prevention, care and
- amfAR Urges Iran to Release Missing HIV/AIDS Doctors
- PRNewswire - August 5, 2008
- -- CEO of amfAR, The Foundation for AIDS Research, calls the reported detention of two Iranian doctors known for their pioneering work on HIV/AIDS extremely troubling. NEW YORK, Aug. 5 /PRNewswire-USNewswire/ -- Kevin Robert Frost, CEO of amfAR, The Foundation for AIDS Research, expressed deep concern today over the re
- Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines: HIV-Infected Women and Non-Whites New to Antiretroviral Therapy Respond Similarly to Men and Whites
- PRNewswire - August 5, 2008
- MEXICO CITY, Aug. 5 /PRNewswire-FirstCall/ -- Initial treatment regimens containing once-daily or twice-daily dosing of Abbott s (NYSE:ABT) protease inhibitor Kaletra (R) ( lopinavir / ritonavir ) tablet provided similar results for contr
- Jesse Milan to Address 2008 International AIDS Conference
- PRNewswire - August 5, 2008
- -- Jesse Milan, Altarum Institute VP and Chairman of the Black AIDS Institute, to be Keynote Speaker at Mexico City Business Council on AIDS WASHINGTON, Aug. 5 /PRNewswire/ -- Jesse Milan, Jr., Vice President of Altarum Institute and a prominent leader and advocate on HIV/AIDS issues, will address the 2008 Mexico City
- Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008: Phase IIb study examines efficacy and safety of once-daily TMC278 in treatment-naive adults with HIV-1
- PRNewswire - August 5, 2008
- MEXICO CITY, Aug. 5 /PRNewswire/ -- New phase IIb data from Tibotec Pharmaceuticals Ltd. provides additional information on the safety and efficacy of TMC278, the company s once-daily, investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), as part of HIV combination therapy in treatment-naive adult
- TMC278 Demonstrates Long-Term Efficacy and Tolerability in Treatment-Naïve Adults With HIV: Ninety-Six-Week Data on Tibotec Investigational NNRTI Presented at AIDS 2008
- PRNewswire - August 5, 2008
- MEXICO CITY, Mexico, August 5/PRNewswire/ -- New phase IIb data from Tibotec Pharmaceuticals Ltd. show that TMC278, the company s once-daily, investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), provides long-term efficacy and tolerability in treatment-naïve adults with HIV. Ninety-six-week study res
- New Report Finds Investment in AIDS Vaccine and Microbicide R&D Continues to Increase Incrementally in 2007
- PRNewswire - August 5, 2008
- -- Calls for Sustained Funding to Maintain HIV Prevention Research Efforts MEXICO CITY, Aug. 5 /PRNewswire-USNewswire/ -- A new report released today shows that funding for biomedical HIV prevention research and development (R&D), including AIDS vaccines and microbicides, increased dramatically between 2000 and 200
- Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
- PRNewswire - August 5, 2008
- -- 88% of patients achieve undetectable HCV RNA levels following 4 weeks of treatment with R7128 1000mg BID with Pegasys(R) plus Copegus(R) -- Safety and tolerability comparable to placebo administered with Pegasys plus Copegus PRINCETON, N.J., Aug. 5 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) announces t
- Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors: PhenoSense(R) Integrase Now Enables Clinicians to Monitor Activity of New Class of Potent Antiretroviral Drugs
- PRNewswire - August 4, 2008
- SOUTH SAN FRANCISCO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced the launch of its PhenoSense(R) Integrase assay, built on Monogram s proprietary technology platform, PhenoSense(R). The assay directly measures the susceptibility of HIV to a new and potent class of
- Latest CDC Report on HIV Incidence Grossly Excludes Hispanics in 2006, the Fastest Growing Ethnic Population in the United States and its Territories
- PRNewswire - August 4, 2008
- MEXICO CITY, Aug. 4 /PRNewswire-USNewswire/ -- In an apparent reversal of CDC s January 2008 decision to revise the number of new Hispanic HIV/AIDS diagnoses based on the inclusion of Puerto Ricans as Hispanics, the latest CDC report released in August 2008, entitled Estimation of HIV Incidence in the Unit
- Landmark Global Survey of People Living with HIV and AIDS Shows Concerning Results that Side Effects are Leading Cause for U.S. Respondents to Discontinue or Switch Treatment Regimens
- PRNewswire - August 4, 2008
- -- Despite 25 Years of Pandemic, U.S. Respondents Are Still Concerned about Stigma and Discrimination MEXICO CITY, Aug. 4 /PRNewswire/ -- Results from the groundbreaking AIDS Treatment for Life International Survey (ATLIS), which polled nearly 3,000 HIV-positive patients from 18 countries, show that a concerning number
- JAMA Commentary Opposes Criminal Punishment for HIV Exposure/Transmission: Authors to Discuss Issue at International AIDS Conference, August 3-8
- PRNewswire - August 4, 2008
- CHICAGO, Aug. 4 /PRNewswire/ -- Criminal punishment for exposure to or transmission of HIV does nothing to reduce the spread of the virus. Instead, it increases stigma and drives people away from accessing care, while disproportionately burdening women and other vulnerable groups who are unable to disclose their HIV st
- As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM
- PRNewswire - August 4, 2008
- -- Ban Ki-moon, Margaret Chan, and presidents from Africa and Latin America call for governments to target epidemic among men who have sex with men MEXICO CITY, Aug. 4 /PRNewswire-USNewswire/ -- A day after leaders from the United Nations and the World Health Organization called attention to the need to combat AIDS amo
- AIDS Action Committee Applauds Legislature for Taking Action to Protect Patient Privacy Within New Electronic Medical Records System
- PRNewswire - August 4, 2008
- -- Measures on privacy and data security set foundation for future systems BOSTON, Aug. 4 /PRNewswire-USNewswire/ -- AIDS Action Committee of Massachusetts, Inc. (AAC) commends state lawmakers for passing legislation that includes privacy and data security protections within a statewide electronic medical records syste
- New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option
- PRNewswire - August 3, 2008
- -- Now is the time to anticipate and plan for various study outcomes MEXICO CITY, Aug. 3 /PRNewswire/ -- The AIDS Vaccine Advocacy Coalition (AVAC) today released a new report, Anticipating the Results of PrEP Trials, calling for increased action from governments, global health institutions, donors, researchers, and ad
- Growing Epidemic in Gay and Bisexual Men in the United States Heightens the Call for a National AIDS Strategy Bridging Race and Sexuality
- PRNewswire - August 3, 2008
- MEXICO CITY, Aug. 3 /PRNewswire-USNewswire/ -- In the wake of disturbing news about higher HIV rates in the United States , people living with HIV and allies are calling for a national AIDS strategy that confronts the homophobia, violence and bias at the heart of the U.S. epidemic. The Centers for Disease Control and P
- Estimate of Annual HIV Incidence Increases to 56,300: Release Of New Estimate Shows Need For A National Aids Strategy
- PRNewswire - August 2, 2008
- WASHINGTON, Aug. 2 /PRNewswire-USNewswire/ -- The federal Centers for Disease Control and Prevention s (CDC) long anticipated revised estimate of annual new cases of HIV infections was revealed today in a paper published in the Aug. 6, 2008 issue of the Journal of the American Medical Association (JAMA). The revise
- New HIV Infection Figures from CDC Underscore Need for National AIDS Strategy for the U.S.
- PRNewswire - August 2, 2008
- -- Announcement of increased new infections in 2006 follows nearly two-year delay in releasing data WASHINGTON, Aug. 2 /PRNewswire-USNewswire/ -- The new HIV infection figures by the Centers for Disease Control and Prevention (CDC) increase the estimate of new HIV infections in 2006 from 40,000 to 56,300. Though the ag
- Estimate of Annual HIV Incidence Increases Significantly; New Estimate Will Show Need For a National AIDS Strategy
- PRNewswire - August 1, 2008
- WASHINGTON, Aug. 1 /PRNewswire-USNewswire/ -- The federal Centers for Disease Control and Prevention s (CDC) long anticipated revised estimate of annual new cases of HIV infections will be revealed on Aug. 3 in a paper published in the Journal of the American Medical Association (JAMA). The revised estimated number of
- Kay Warren Reveals Solution to Gender-Based Violence: The Worldwide Church, Which Offers Hope to the World;
- PRNewswire - August 1, 2008
- -- Warren Presents Church-based Strategy of Hope and Healing in Plenary, Workshop at Ecumenical Alliance Conference in Mexico City MEXICO CITY, Aug. 1 /PRNewswire/ -- Kay Warren, international AIDS advocate, author and director of the HIV/AIDS Initiative at Saddleback Church in Lake Forest, Calif., today addressed the
- Ford Foundation Says Rights and Opportunity Are Critical for People Living Longer with HIV: Advanced Treatment is Extending Lives, but Social Progress is Needed for People to Live Full Lives with the Disease
- PRNewswire - August 1, 2008
- MEXICO CITY, Aug. 1 /PRNewswire-USNewswire/ -- As millions of people across the globe begin accessing treatment and care for HIV/AIDS, the Ford Foundation today said that creating a world where people with HIV/AIDS can lead full lives with dignity, purpose and access to opportunity is a critical priority in the global
- International AIDS Conference an 'Expensive Talking Shop' Unless More Done for Children: World Vision calls for action to protect, care for children impacted by HIV and AIDS
- PRNewswire - August 1, 2008
- -- Mexico City event a chance to spur help for millions of orphans and vulnerable children MEXICO CITY, Aug. 1 /PRNewswire/ -- A leading humanitarian agency has today warned that the world s biggest conference on HIV and AIDS will miss the mark unless attendees come away making firm commitments to end mother-to-child t
- Ann Lion Coleman Joins Abt Associates to Direct USAID Health Systems 20/20 Project
- PRNewswire - July 31, 2008
- CAMBRIDGE, Mass., July 31 /PRNewswire/ -- HIV/AIDS and health systems expert Ann Lion Coleman will join Abt Associates as Director for the Health Systems 20/20 project in August 2008. Health Systems 20/20 is the USAID Bureau of Global Health s flagship project working to strengthen health systems by using an integrated
- African American-Owned Condom Company Fears the Widening AIDS Epidemic
- PRNewswire - July 31, 2008
- WEST MEMPHIS, Ark., July 31 /PRNewswire/ -- When Kirk Manuel speaks, you hear anguish in his voice. You hear the heartbreak of a man who has see one too many members of his community impacted by HIV and AIDS. When Kirk Manuel speaks, you hear courage in his voice, too. You hear a man who believes in his product, Head S
- Higher Number of HIV Infections Must Translate Into Leadership & Action by U.S. Government
- PRNewswire - July 31, 2008
- -- Additional Funding for HIV Prevention & Sound Public Policies Needed WASHINGTON, July 31 /PRNewswire-USNewswire/ -- As the world s attention turns to the global HIV/AIDS epidemic with the convening of the International AIDS Conference in Mexico City, the U.S. Centers for Disease Control and Prevention (CDC) is a
- Catholics at International AIDS Conference XVII Tell Pope: End Ban on Condoms
- PRNewswire - July 31, 2008
- MEXICO CITY, July 31 /PRNewswire-USNewswire/ -- As thousands gather in Mexico City for the 17th International AIDS Conference August 3-8, 2008, Catholics for Choice and its Latin American sister organizations, Catolicas por el Derecho a Decidir, will be highlighting Catholic opposition to the Vatican s ban on condoms u
- The Latino Commission on AIDS Releases Report on the State of HIV/AIDS in Latino/Hispanic Communities in the United States on the Eve of the International AIDS Conference in Mexico City
- PRNewswire - July 30, 2008
- -- A National Delegation of the Commission will dialogue with leaders at the Conference to share and learn about successful strategies in response to the HIV/AIDS pandemic NEW YORK, July 30 /PRNewswire-USNewswire/ -- Hispanics in the United States are the second most affected community, it is estimated that more than 2
- Bill & Melinda Gates Congratulate President Bush on Signing of AIDS, TB, and Malaria Funding Reauthorization Bill
- PRNewswire - July 30, 2008
- SEATTLE, July 30 /PRNewswire-USNewswire/ -- President George W. Bush today signed legislation that reauthorizes the President s Emergency Plan for AIDS Relief (PEPFAR) and other global health funding. In response, Bill and Melinda Gates, co-chairs of the Bill & Melinda Gates Foundation, made the following statement
- National Medical Association Installs 109th President at Atlanta Convention: New NMA President to Address Cancer and Mental Health Disparities
- PRNewswire - July 30, 2008
- ATLANTA, July 30 /PRNewswire-USNewswire/ -- Delivering her inaugural address as the 109th president of the National Medical Association (NMA), Carolyn Barley Britton, M.D., M.S., shared her plans to focus on cancer and mental health disparities during her administration. The NMA is the nation s premier organization for
- AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs
- PRNewswire - July 30, 2008
- WASHINGTON, July 30 /PRNewswire-USNewswire/ -- On Wednesday, July 30th, Representative Jose Serrano (D-NY) introduced the Community AIDS and Hepatitis Prevention Act, a bill which, if passed, will remove all legal barriers to States and local jurisdictions to spend federal funding that they receive for prevention of di
- Ramsell Pharmacy Solutions and Mirixa Announce National Pharmacy Initiative to Serve People Living with HIV/AIDS
- PRNewswire - July 30, 2008
- -- Innovative HIV/AIDS Program for Public Health Insured Patients to be Delivered by Community Pharmacists using Mirixa technology RESTON, Va. and OAKLAND, Calif., July 30 /PRNewswire/ -- Mirixa Corporation and Ramsell Pharmacy Solutions jointly announced today the launch of a pharmacist-delivered medication therapy ma
- Bush to Sign AIDS Bill Today, but Funding Still Missing
- PRNewswire - July 30, 2008
- WASHINGTON, July 30 /PRNewswire-USNewswire/ -- Today President Bush will sign into law a major new piece of legislation on global AIDS, tuberculosis and malaria, but Congress is not providing the money to implement it for fiscal year 2009. We deeply appreciate the hard work of everyone involved, in the Congress and the
- New 'From-the-Ground' Report Reformulates Simplistic Argument About HIV/ AIDS and Health Care Systems in a Fundamental Way
- PRNewswire - July 30, 2008
- -- Dr. Jim Kim of Harvard School of Public Health joins International Treatment Preparedness Coalition to release new report and call for broad, systematic approach to HIV/AIDS and health care scale up NEW YORK and HARARE, Zimbabwe and BOSTON and SAO PAULO, Brazil , July 29 /PRNewswire-USNewswire/ -- T
- ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
- PRNewswire - July 29, 2008
- FREDERICK, Md., July 29 /PRNewswire/ -- ImQuest BioSciences announced today the successful acquisition of funding from the National Institute of Allergy and Infectious Disease (NIAID/NIH) to support the development of pyrimidinedione inhibitors as topical microbicides to prevent the sexual transmission of HIV. The two
- Three Rs and HIV/AIDS Mark New Haiti Literacy Plan
- PRNewswire - July 29, 2008
- WASHINGTON, July 29/PRNewswire-USNewswire/ -- Increasing literacy and curbing HIV/AIDS is the centerpiece of the U.S. Agency for International Development s (USAID) new three-year effort designed to stabilize parts of Haiti plagued by community unrest. The Haiti Basic Education Project -- a $19 million investment -- wi
- Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
- PRNewswire - July 29, 2008
- -- Initiates IDX184 Phase I Clinical Study and Advances HCV Protease Inhibitor and Non-Nucleoside Polymerase Inhibitor Clinical Candidates into IND-Enabling Preclinical Studies ~ CAMBRIDGE, Mass., July 29 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the di
- Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System
- PRNewswire - July 28, 2008
- Partnership Will Modernize All Regional Hospital Laboratories to Improve Access to Care Across the Country DAR ES SALAAM, Tanzania , July 28 /PRNewswire-FirstCall/ -- At a ceremony today, the Ministry of Health and Social Welfare, United Republic of Tanzania, and Abbott Fund commemorated the latest step in a nationwide
- Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting
- PRNewswire - July 28, 2008
- SAN DIEGO, July 28 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced that data will be presented on RDEA806, the Company s novel investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for patients with human immunodeficiency virus (HIV) at the 48th Annual ICAAC/IDSA 46th An
- AIDS Vaccines: Where Do We Go From Here?
- PRNewswire - July 28, 2008
- The International AIDS Vaccine Initiative (IAVI) and Key Thought Leaders Explore Critical Next Steps for AIDS Vaccine Research at the 17th International AIDS Conference in Mexico City NEW YORK, July 28 /PRNewswire-USNewswire/ -- The following was released today by the International AIDS Vaccine Initiative: WHAT: To
- Media Advisory (Telephone Press Conference): Is Donor AIDS Money Strengthening Health Systems? New Study Finds Missed Opportunities
- PRNewswire - July 28, 2008
- The Center for Global Development will hold a telephone press conference on July 29, 2008 to introduce new research ahead of the official launch event at the International AIDS Conference in Mexico City. The report, Seizing the Opportunity on AIDS and Health Systems, finds that billions of dollars in donor money being
- HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference
- PRNewswire - July 27, 2008
- RESEARCH TRIANGLE PARK, N.C., July 27 /PRNewswire/ -- Timothy Mastro, MD, FACP, DTM&H, who joins Family Health International (FHI) on August 1st as Senior Director of Research, will share information on promising research into pre-exposure prophylaxis (PrEP) for HIV prevention at the International AIDS Conference i
- Congress Sends Global HIV/AIDS Legislation to the President
- PRNewswire - July 24, 2008
- WASHINGTON, July 24 /PRNewswire-USNewswire/ - The landmark U.S. effort to fight HIV/AIDS around the world will be expanded and extended by five years thanks to legislation that Congress passed today. By a vote of 303 to 115, the House approved Senate amendments to the Tom Lantos and Henry J. Hyde United Stat
- Pelosi Statement on House Passage of Global AIDS Legislation
- PRNewswire - July 24, 2008
- WASHINGTON, July 24 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi released the following statement this evening in support of the Tom Lantos and Henry J. Hyde Global Leadership Against HIV/Aids, Tuberculosis, and Malaria Reauthorization Act of 2008. The bill, which passed the Senate last week, passed the House this e
- Webcast Alert: JAMA Media Briefing on HIV/AIDS
- PRNewswire - July 24, 2008
- MEXICO CITY, July 24 /PRNewswire/ -- New research from the Journal of the American Medical Association (JAMA) theme issue on HIV/AIDS will be released to the media, coinciding with the International AIDS Conference. Four of the world s top HIV/AIDS researchers will present their findings on new therapies, treatment gui
- Studies Assessed by European Health Authority Conclude That Impurity in Roche's Viracept(R) (nelfinavir mesylate) Did Not Increase Patient's Risk of Cancer
- PRNewswire - July 24, 2008
- Basel, Switzerland (PRNewswire) - The European Committee for Human Medicinal Products (CHMP) has confirmed that the presence of an impurity called ethyl methanesulfonate (EMS) in Roche s Viracept (nelfinavir mesylate) did not increase patients risk of developing cancer.
- Latino Commission on AIDS Welcomes Miss Universe 2008 Dayana Mendoza as its Newest 'Madrina' in the Fight Against AIDS
- PRNewswire - July 24, 2008
- NEW YORK, July 24 /PRNewswire-USNewswire/ -- Miss Universe 2008 Dayana Mendoza is the newest Madrina of the Latino Commission on AIDS, announced Dennis deLeon, President of the Latino Commission on AIDS. Dayana Mendoza visited the offices of the Commission in New York on July 23rd and received a comprehensive briefing
- GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine
- PRNewswire - July 22, 2008
- -- Partnership creates worldwide strategic collaboration between Vivalis and GeoVax ATLANTA and NANTES, France , July 22 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Viru
- Cavidi Calls for Greater Access to HIV Monitoring at AIDS 2008 Conference in Mexico
- PRNewswire - July 22, 2008
- UPPSALA, Sweden , July 22 /PRNewswire/ -- Cavidi is attending the XVII International AIDS Conference in Mexico City, August 3-8, 2008 to spread its message of the need for greater access to HIV viral load monitoring. Lately the supply of HIV medicines (ARVs) to the developing world has been increasing. This is a wonder
- Presumed Presidential Nominees McCain and Obama to Make First Joint Campaign Appearance on August 16 at Saddleback Church
- PRNewswire - July 21, 2008
- Pastor Rick Warren to Host Saddleback Civil Forum on Leadership and Compassion and Question Candidates on Faith and the Common Good LAKE FOREST, Calif., July 21 /PRNewswire-USNewswire/ -- Sens. John McCain and Barack Obama, respective presumed Republican and Democratic presidential nominees, will end the primary season
- VIRxSYS to Host a Web Conference to Announce Clinical Trial Update: Summary of data from five 2008 conferences
- PRNewswire - July 21, 2008
- GAITHERSBURG, Md., July 21 /PRNewswire/ -- VIRxSYS Corporation, a privately held company developing gene therapies for HIV and genetic diseases, will present an update on the VRX496 Phase I and Phase II clinical trials for the media and members of the advocacy community. VRX496 is an investigational gene therapy for th
- Catholics Asked to Tell Their Bishops to End Ban on Contraception
- PRNewswire - July 21, 2008
- -- July 25th Marks 40th Anniversary of Vaticans Devastating Decision WASHINGTON, July 21 /PRNewswire-USNewswire/ -- Forty years ago, a decision was announced that has had a catastrophic impact on the poor and powerless around the world. On July 25, 1968, Pope Paul VI slammed the door on the hopes of the vast majority o
- Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
- PRNewswire - July 17, 2008
- -- Once-daily TMC278, the third anti-HIV compound to be developed in Tibotec virology portfolio YARDLEY, Pa., July 17 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. announced today that two major phase III efficacy trials examining TMC278, its investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in tre
- Senate Committee Approves $1.4 Million for Development of National AIDS Strategy
- PRNewswire - July 17, 2008
- WASHINGTON, July 17 /PRNewswire-USNewswire/ -- Last week, the Senate Appropriations Committee passed the Financial Services appropriations bill for the coming fiscal year that includes $1.4 million to the White House Office of National AIDS Policy for the development of a National AIDS Strategy. The House of Representa
- Ardea to Present Data on Lead HIV Candidate, RDEA806, at XVII International AIDS Conference
- PRNewswire - July 17, 2008
- SAN DIEGO, July 17 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA - News) today announced that Dr. Graeme Moyle, Director of HIV Research, Chelsea and Westminster Hospital, will present results from the Phase 2a proof-of-concept monotherapy study of RDEA806, during an oral presentation at a late breake
- Diplomat's 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
- PRNewswire - July 17, 2008
- SWARTZ CREEK, Mich., July 17, 2008 /PRNewswire via COMTEX/ -- Diplomat Specialty Pharmacy, the nation s largest independent specialty pharmacy, released today results of their Spring 2008 Patient Satisfaction Survey. The national survey was mailed to 1500 patients, randomly selected from its own database of approximate
- Senate Passes Landmark AIDS, TB and Malaria Bill, Says Global AIDS Alliance
- PRNewswire - July 16, 2008
- WASHINGTON, July 16 /PRNewswire-USNewswire/ -- Today the U.S. Senate passed a crucial bill, backed by President Bush, that reauthorizes the U.S. program on global HIV/AIDS while also authorizing much greater funding for programs to address tuberculosis and malaria. The bill is a tremendous achievement, and I commend Se
- AIDS Action Commends Senate Passage of PEPFAR Reauthorization
- PRNewswire - July 16, 2008
- WASHINGTON, July 16 /PRNewswire-USNewswire/ -- AIDS Action applauds the Senate for overwhelming, bipartisan passage of the Lantos/Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act (S 2731), which reauthorizes the President s Emergency Plan For AIDS Relief (PEPFAR). The organiza
- Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews
- PRNewswire - July 16, 2008
- -- INTERNATIONAL AIDS SOCIETY AND KAISER FAMILY FOUNDATION PARTNER TO OFFER DAILY, COMPREHENSIVE COVERAGE OF CONFERENCE FOR FREE MENLO PARK, Calif., and GENEVA, July 16 /PRNewswire-USNewswire/ -- The International AIDS Society (IAS) and the Kaiser Family Foundation will provide worldwide online access to the XVII Inter
- 25,000 AIDS Walk San Francisco Participants; 25,000 Reasons Why
- PRNewswire - July 16, 2008
- For every walker, there is a story ... SAN FRANCISCO, July 16 /PRNewswire/ -- I walk because ... is a simple idea that explains the motivation behind one of the world s most successful fundraising events. Virtually all walkers have at least one story to explain their participation in AIDS Walk San Francisco (AWSF), whi
- Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
- PRNewswire - July 14, 2008
- -- Achieves Record Revenues While Advancing Three Major Clinical Programs and Securing 5-Year Contract With U.S. Defense Threat Reduction Agency Worth Up to $44.4 Million TUSTIN, Calif., July 14 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM - News), today announced financial results for fiscal
- Senator Vitter Threatens Crucial AIDS Bill
- PRNewswire - July 14, 2008
- To: POLITICAL EDITORS WASHINGTON, July 14 /PRNewswire-USNewswire/ -- Millions of lives are at stake today as the Senate prepares to vote on crucial global AIDS, TB and malaria legislation (S. 2731). The debate on the Senate floor is expected to begin this afternoon, and this is the last chance for the bill to be approv
- Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding
- PRNewswire - July 11, 2008
- To: NATIONAL EDITORS WASHINGTON, July 11 /PRNewswire-USNewswire/ -- In a letter to the Senate, forty-five leading human rights and global health organizations urge policymakers to address critical shortfalls in legislation that would reauthorize the Presidents Plan for AIDS Relief (PEPFAR). With the Senate poised to vo
- HIV Infusion Clinic Administrator Sentenced to 30 Months in Prison For Health Care Fraud
- PRNewswire - July 10, 2008
- To: NATIONAL EDITORS WASHINGTON, July 10 /PRNewswire-USNewswire/ -- Miami resident Aisa Perera, 42, was sentenced today to 30 months in prison for her role in an $11 million scheme to defraud the Medicare program, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U.S. Attorney R. Alexande
- ImQuest Awarded SBIR Grant to Define the Mechanism of Action of Their Lead Anti-HIV Therapeutic Compound IQP-0410
- PRNewswire - July 9, 2008
- FREDERICK, Md., July 9 /PRNewswire/ -- ImQuest Life Sciences announced today the successful acquisition of funding from the National Institutes of Health to define the mechanism of action of their dual-acting pyrimidinedione HIV inhibitor IQP-0410. The objective of this one-year Small Business Innovative Research (SBIR
- Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout
- PRNewswire - July 9, 2008
- -- Dr. Fernando Perez-Ruiz Joins Ardea s Inflammatory Disease Scientific Advisory Board SAN DIEGO, July 9 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA - News) today announced that it has received regulatory approval to begin a Phase 2a proof-of-concept clinical trial evaluating RDEA806 in gout patien
- Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
- PRNewswire - July 9, 2008
- -- Transgenic Animals to be Developed for Therapeutic and Diagnostic Applications ST. LOUIS and RICHMOND, Calif., July 9 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL - News) and Sangamo BioSciences, Inc. (Nasdaq: SGMO - News) today announced a research and license agreement to provide Roche (SWX: R
- Gates Foundation Welcomes G8 Commitments and Urges Follow Through to Address Problems Affecting the World's Poor
- PRNewswire - July 8, 2008
- -- Foundation announces additional US$150 million for Polio Eradication SEATTLE, July 8 /PRNewswire/ -- The Bill & Melinda Gates Foundation released the following statement regarding the G8 Summit: The Bill & Melinda Gates Foundation welcomes the renewed commitment by leaders of the Group of Eight countries to
- Nurse Practitioner Healthcare Foundation Fellows Have an Impact on Public Health and Health Policy: Nurse Practitioners at the Office of the Surgeon General Address Obesity and Health Communication
- PRNewswire - July 8, 2008
- BELLEVUE, Wash., July 8 /PRNewswire/ -- At a time when questions surround the U.S. health care system, two Nurse Practitioner Healthcare Foundation (NPHF) Senior Health Fellows are working to influence U.S. health policy. Mary Beth Bigley, DrPH, MSN, ANP, and Catherine Wisner, PhD, FNP, nurse practitioners (NPs) and re
- Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
- PRNewswire - July 7, 2008
- -- 96-week comparative study of Clevudine versus Viread (R) versus Clevudine+Viread(R) in 150 patients with chronic hepatitis B PRINCETON, N.J., July 8 /PRNewswire-FirstCall/ -- The French National Agency for Research on AIDS and Viral Hepatitis (ANRS), with the support of Pharmasset, Inc. (Nasdaq: VRUS) and
- AIDS Walk San Francisco Takes Big Green Step Forward: San Francisco's Largest AIDS Fundraising Event Goes GREEN with Online Communications, Recycling and Awareness
- PRNewswire - July 7, 2008
- SAN FRANCISCO, July 7 /PRNewswire/ -- The San Francisco AIDS Foundation and AIDS Walk San Francisco announced today key initiatives to Green the HIV fundraising event that is already a San Francisco institution. The initiatives include the introduction of Green Walkers, composting, and enhanced recycling. With the Foun
- GeoVax Reports Progress on Its AIDS Vaccine Technology
- PRNewswire - July 7, 2008
- ATLANTA, July 7 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based, publicly traded biopharmaceutical company specializing in the prevention and treatment of infectious diseases, today provided an operational update on the company s progress towards entering Phase 2 preventative hu
- Leading Vaccine Expert Joins IAVI
- PRNewswire - July 3, 2008
- NEW YORK, July 3 /PRNewswire-USNewswire/ -- Dr. Thomas Hassell, former global vice president of process development at sanofi pasteur, a leading vaccine company, has joined IAVI as vice president for vaccine development. In his new role, Dr. Hassell will lead IAVI s product development efforts that are aimed at rapidly
- USAID Announces Youth-Focused HIV/AIDS Programs in Ethiopia
- PRNewswire - July 1, 2008
- Contact: U.S. Agency for International Development Press Office, +1-202-712-4310 ADDIS ABABA, Ethiopia , July 1 /PRNewswire-USNewswire/ -- The U.S. Agency for International Development (USAID) awarded a $500,000 grant to the YMCA of the USA to combat HIV/AIDS in Ethiopia. The program will provide youth access to basic
- (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa - Led by Don MacKinnon, Founder of HEAR Music
- PRNewswire - June 30, 2008
- NEW YORK, June 30 /PRNewswire/ -- In the fall of 2008, (RED) will unveil a simple, seamless way for people to receive music from artists they love and artists they will discover through (RED). By applying the (RED) idea to music this new model will create a new revenue stream for artists and labels and buy life-saving
- Tobira Therapeutics Inc. Announces Senior Management Team: Senior management team possessing over 130 years of cumulative expertise
- PRNewswire - June 30, 2008
- PRINCETON, N.J. and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the organization of the company s senior management team. Tobira Therape
- Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells: Preclinical Animal Data Demonstrates Promising Therapeutic Strategy for HIV/AIDS
- PRNewswire - June 30, 2008
- RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by treatment with zinc finger DNA-binding protein nucleases (ZFN(TM)). The data suggest t
- Earvin 'Magic' Johnson and Abbott Bring 'I Stand with Magic' Program: Part of the Campaign to End Black HIV/AIDS to Facebook Community
- PRNewswire - June 27, 2008
- ABBOTT PARK, Ill., June 27 /PRNewswire-FirstCall/ -- Summary -- In conjunction with National HIV Testing Day, the Magic Johnson Foundation, http://www.magicjohnson.org/ and Abbott (NYSE:ABT) , http://www.abbott.com/, launched a new Facebook group to further engage young adults in the I Stand With Magic , http://istandw
- AIDS Action Expresses Deep Disappointment With Proposed Congressional Funding Levels for HIV Prevention on National HIV Testing Day, June 27
- PRNewswire - June 27, 2008
- WASHINGTON, June 27 /PRNewswire-USNewswire/ -- AIDS Action criticizes Congress on National HIV Testing Day for substantially under-funding domestic HIV/AIDS prevention programs at the Centers for Disease Control and Prevention (CDC). House and Senate Appropriators have both proposed HIV/AIDS spending bills that allocat
- Montblanc Supports 46664 and The Nelson Mandela Foundation
- PRNewswire - June 26, 2008
- Lutz Bethge, CEO Montblanc International Announces Brand as Worldwide Sales Partner of the Exclusive Mandela 46664 Bangle NEW YORK, June 26 /PRNewswire/ -- Montblanc announced today their partnership with The Nelson Mandela Foundation, signing on as the first retailer that will support sales of their signature 46664 ba
- European Approval for Roche's Pegasys Personalises Treatment for a Subgroup of Hepatitis C Patients: Chance for Cure With Only Four Months of Treatment
- PRNewswire - June 26, 2008
- BASEL, Switzerland , June 26/PRNewswire/ -- Roche Also Announces Start of NCORE Study to Determine Best Length of Treatment in Patients who do not Experience a Rapid Response Roche announced today that the European Commission has approved a shortened, 16-week course of treatment with Pegasys (peginterferon alfa-2a (40
- National HIV Survey Finds Support for Routine Testing
- PRNewswire - June 26, 2008
- WASHINGTON, June 26 /PRNewswire-USNewswire/ -- In recognition of National HIV Testing Day, Friday, June 27th, Test for Life released a national survey on attitudes surrounding HIV and AIDS as part of its national campaign to prevent the spread of HIV/AIDS and ensure access to care for those who test positive. At least
- Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets
- PRNewswire - June 25, 2008
- -- First-to-File Status Will Provide 180-Day Marketing Exclusivity Upon Final Approval PRINCETON, N.J., June 25 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL), announced today that the company has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Valganciclovir Hydroch
- Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
- PRNewswire - June 25, 2008
- -- Once-daily dosing with enteric-coated tablet produced robust antiviral activity -- RDEA806 was well tolerated during one week of dosing in HIV patients SAN DIEGO, June 25 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced additional positive results from its completed Phase 2a proof-of-c
- The National Latino AIDS Action Agenda Network (NLAAN) Releases Federal Policy Recommendations - Addressing the Latino AIDS Crisis
- PRNewswire - June 25, 2008
- -- Elected Officials and Community Leaders Officially Announce Federal Policy Recommendations NEW YORK, June 25 /PRNewswire/ -- The Latino Commission on AIDS and its community partners join eight cities across the United States (Los Angeles, New York, Washington, DC, Philadelphia, Pu
- NICE Issues Final Appraisal Determination (FAD) Which Recommends Baraclude(R) (Entecavir) as a Treatment Option for Eligible Chronic Hepatitis B Patients
- PRNewswire - June 25, 2008
- UXBRIDGE, England, June 25/PRNewswire/ -- NICE (National Institute for Health and Clinical Excellence) has announced today, in its Final Appraisal Determination (FAD), that Baraclude(R) (entecavir) is recommended as an option for treatment of eligible patients with chronic hepatitis B (CHB). Entecavir is a potent anti-
- European Commission Approves REYATAZ(R) (Atazanavir Sulfate 100mg, 150mg, 200mg, 300mg), in Combination With Other Antiretroviral Medicinal Products, for use in Treatment Naïve HIV-1 Infected Adults
- PRNewswire - June 24, 2008
- -- REYATAZ(R), Taken With Ritonavir , Provides an Additional Therapy Option in Treatment-Naïve HIV-1 Infected Adults in the European Union PARIS, June 24/PRNewswire/ -- The European Commission has granted marketing authorization for REYATAZ(R) (atazanavir sulfate 300mg once daily), administered with ritonavir 100 mg on
- New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients
- PRNewswire - June 24, 2008
- -- APTIVUS Oral Solution Also Approved for Treatment-Experienced Adult Patients RIDGEFIELD, Conn., June 24 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration ( FDA ) granted approval of Aptivus(R) (tipranavir) capsules/oral solution with dosing informat
- A Contribution of Leadership Skills to a Growing African AIDS Group
- PRNewswire - June 24, 2008
- -- The following is an op-ed by Frank Waltmann, Head Corporate Learning, Novartis BASEL, Switzerland , June 24/PRNewswire/ -- Corporate philanthropy in Africa can come in many forms. Financial funding and product donations are often heralded, but perhaps its time for other, more specialized forms of giving to take thei
- MAC Cosmetics Celebrates With Nelson Mandela at the 46664 Concert in Hyde Park
- PRNewswire - June 23, 2008
- LONDON, June 23/PRNewswire/ -- MAC Cosmetics is proud to announce its involvement in the 46664 Concert honouring Nelson Mandela at 90 taking place in Hyde Park on the 27th June 2008. Many of the world s most powerful and instantly recognisable figures and a concert audience of 46,664 will pay their tributes to one of t
- Verizon Wireless Continues Support of National HIV Testing Awareness Campaign: Company Working with Education and Public Health Experts to Raise Public Awareness Via Mobile Media
- PRNewswire - June 23, 2008
- ALPHARETTA, Ga., June 23 /PRNewswire/ -- The message about the importance of HIV testing is getting out to the general public, thanks to the innovative use of wireless communications. Verizon Wireless, the company with the nation s most reliable wireless voice and data network, announced today its continued effort to d
- Family Health International Awarded USAID 'Progress' Project to Improve Family Planning and Reproductive Health Programs in Developing Countries
- PRNewswire - June 20, 2008
- -- USAID to Invest US $50 Million over a Five-Year Period to Improve Access and Availability to Family Planning RESEARCH TRIANGLE PARK, N.C., June 20 /PRNewswire-USNewswire/ -- The U.S. Agency for International Development (USAID) has announced that Family Health International (FHI) -- a global public health and develo
- Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men
- PRNewswire - June 19, 2008
- -- Schmidt teams up with Minor League Baseball(TM) to raise awareness of Benign Prostatic Hyperplasia (BPH), a condition affecting more than 8 million men in the U.S. BRIDGEWATER, N.J., June 19 /PRNewswire-FirstCall/ -- Hall of Fame third baseman and Philadelphia Phillies legend Mike Schmidt and Minor League Baseball(T
- Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies: PhenoSense GT(TM) and PhenoSense Integrase(TM) assays used to study promising new Integrase inhibitor
- PRNewswire - June 18, 2008
- SOUTH SAN FRANCISCO, Calif., June 18 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc., (NASDAQ:MGRM) announced today that the Company has signed an agreement with Gilead Sciences , Inc. to provide resistance testing and consultative services for Gilead s Elvitegravir Phase III studies. Monogram assays will be used
- Patient Data Analysis Report Finds More Than 75 Percent of Chronically Ill Patients Unable to Obtain Needed Healthcare Have Some Form of Insurance: New trend findings of 'underinsured' patients based on successful management of nearly 45,000 cases by national, non-profit Patient Advocate Foundation in 2007
- PRNewswire - June 17, 2008
- NEWPORT NEWS, Va., June 17 /PRNewswire-USNewswire/ -- Patient Advocate Foundation (PAF) -- a national non-profit organization providing direct case management services and healthcare information to millions of patients with life-threatening, debilitating and chronic diseases each year who are unable to obtain access to
- New York City Department of Health & Mental Hygiene Awards 2 Million Unit Bid to The Female Health Company
- PRNewswire - June 17, 2008
- CHICAGO, June 17 /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) announced it has received a bid award for two million FC female condoms from the New York City Department of Health and Mental Hygiene. The Company expects shipments to begin immediately, at the direction of the Health Department. The terms
- Dr. Rani G Whitfield, M.D. Unveils 'The Legion of Health': Comic Book Series Delivers Positive Health Messages To Youth Markets
- PRNewswire - June 17, 2008
- BATON ROUGE, La., June 17 /PRNewswire/ -- Dr. Rani G Whitfield, M.D., a family practice and sports medicine physician in Baton Rouge, LA is proud to announce the creation and official release of his comic book series, Volume One Book One Tha Hip Hop Doc - Fed Up! Designed to introduce uniquely packaged health messages
- TalkAIDS: A&PI Wellness Center Launches a New Anti-Stigma Campaign With International Star Joan Chen
- PRNewswire - June 16, 2008
- SAN FRANCISCO, June 16 /PRNewswire-USNewswire/ -- Following a study indicating that strong attitudes against people living with HIV/AIDS exist in the Chinese community, Asian & Pacific Islander Wellness Center has developed a new ad campaign called TalkAIDS to address this issue of stigma in the Chinese community.
- Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy
- PRNewswire - June 16, 2008
- SOUTH SAN FRANCISCO, Calif., June 16 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) today announced that data related to the enhanced performance of the company s HIV tropism assay were presented in an oral presentation at the 17th International HIV Drug Resistance Workshop in Sitges,
- Genetic Immunity to Present at 2008 BIO International Convention
- PRNewswire - June 12, 2008
- MCLEAN, Va. and BUDAPEST, Hungary , June 12 /PRNewswire/ -- Genetic Immunity, a US/Hungarian clinical-stage Company focused on the development of its patented nanomedicines for targeted immune amplification, announced today that the Company will be presenting at the 2008 Bio International Convention to be held June 17-
- Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
- PRNewswire - June 12, 2008
- CAMBRIDGE, Mass., June 12 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported phase I/II data for IDX899, a non-nucleoside reverse transcriptase
- Three Miami Area Brothers and Physician's Assistant Charged In $110 Million Health Care Fraud Scheme
- PRNewswire - June 11, 2008
- WASHINGTON, June 11 /PRNewswire-USNewswire/ -- Three Miami area brothers who allegedly financed 11 corrupt HIV infusion clinics and a physician s assistant who worked at those clinics have been charged in a $110 million HIV infusion fraud scheme, the Department of Justice s Criminal Division and the U.S. Attorney s Off
- NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
- PRNewswire - June 10, 2008
- SAN MATEO, Calif., June 10 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (NASDAQ:NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today the publication of Phase 3 data of its lead product candidate, NGX-4010, in the journal Neurology. The paper, titled,
- The Female Health Company / HLL Receive National AIDS Control Organization of India Order for 1.5 Million FC2 Female Condoms
- PRNewswire - June 10, 2008
- CHICAGO, June 10 /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) which manufactures and markets the FC and FC2 Female Condoms(R), today announces that its technical collaboration with Hindustan Latex Ltd (HLL) has been successful in winning an order from the National AIDS Control Organization of
- MTV and SpinVox Partner to Launch First Ever Integrated Voice Powered Cause-Related Social Networking Campaign 'Stand By What You Say'
- PRNewswire - June 10, 2008
- CAMPAIGN VOICED BY SUPERSTAR KELLY ROWLAND CAUSES PROMOTES CAMPAIGN TO ITS 12 MILLION MEMBERS LONDON and NEW YORK, June 10 /PRNewswire/ -- MTV s Staying Alive Foundation, SpinVox and Causes on Facebook today announced the launch of their joint campaign, Stand By What You Say . The groundbreaking initiative encourages y
- CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference: Findings Suggest New Way to Stimulate the Immune System to Fight Viral Diseases
- PRNewswire - June 9, 2008
- VIENNA, Va., June 9 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (AMEX:CVM) and researchers at Northeastern Ohio Universities Colleges of Medicine and Pharmacy jointly announced favorable new developments in the LEAPS(TM) heteroconjugate vaccine technology developed by CEL-SCI at the FOCIS Immunology meeting in Boston
- Now Playing: Spike Lee Stands with Earvin 'Magic' Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign
- PRNewswire - June 9, 2008
- LOS ANGELES, June 9 /PRNewswire-FirstCall/ -- Today, Earvin Magic Johnson (http://www.magicjohnson.com/index.php?/foundation/), Cookie Johnson, Abbott (http://www.abbott.com/) (NYSE:ABT) and the Magic Johnson Foundation launched a public service announcement campaign as part of the I Stand With Magic Program, part of
- Record-Breaking AIDS/LifeCycle Pedals into Los Angeles, Raising AIDS Awareness, $11.6 Million for HIV/AIDS Services: Riders from 12 Countries, 42 States Complete 545-Mile Trek from San Francisco
- PRNewswire - June 7, 2008
- LOS ANGELES, June 7 /PRNewswire/ -- After a week experiencing the physical and emotional challenges of a 545-mile journey from San Francisco to Los Angeles, the 3,000 participants in AIDS/LifeCycle (ALC) rolled to a victorious finish in West Los Angeles today, having raised some $11.6 million from more than 60,000 dono
- Kaiser Permanente Sued By Executive for AIDS Discrimination
- PRNewswire - June 5, 2008
- SAN FRANCISCO, June 5 /PRNewswire/ -- Jeffery Sterman, Public Affairs Director and voice of Kaiser Permanente in San Francisco for ten years is claiming AIDS discrimination and breach of contract. A person with AIDS, Sterman is one of those who helped create the hospital s response to HIV and AIDS. David J. St. Louis,
- Alternative Extends Partnership With Elizabeth Glaser Pediatric AIDS Foundation
- PRNewswire - June 5, 2008
- -- Premium Lifestyle Brand Supports Foundation s Signature Los Angeles and New York Events for Second Year in a Row with Eco-Friendly Apparel and Green Forest Activity Area LOS ANGELES, June 5 /PRNewswire/ -- Alternative (http://www.alternativeapparel.com), premium fashion statements inspired by and created for free-th
- WHO Report Says 9.7 Million at Risk of Death from AIDS Today; AHF Renews Call for US Congress to Commit to Scale up Treatment to Seven Million Lives
- PRNewswire - June 5, 2008
- LOS ANGELES, June 5 /PRNewswire-USNewswire/ -- The release of a World Health Organization / UNAIDS /UNICEF report on Monday documents appreciable global progress in the effort to deliver lifesaving antiretroviral treatment (ARVs) to people living with HIV/AIDS in developing countries; however, it also underscores the c
- World Class Athlete to Attempt 'Death Valley 810' in Support of AIDS Orphans: Lisa Smith-Batchen to Run 302 Miles, Bike 508 to Benefit 'AIDS Orphans Rising'
- PRNewswire - June 5, 2008
- GRAND TETONS, Idaho, June 5 /PRNewswire/ -- Dreamchasers Outdoor Adventures (http://www.dreamchaserevents.com/doac/index.htm), an organization that helps athletes of all abilities conquer the world s toughest running events, today announced that its founder has planned an unprecedented running and cycling event to rais
- White Ribbon Alliance for Safe Motherhood Challenges World Economic Forum on Africa to Invest in Women's Health: Says Maternal Deaths Indicator of Failures to Provide Basic Health Care to Women
- PRNewswire - June 5, 2008
- CAPE TOWN, South Africa , June 5 /PRNewswire-USNewswire/ -- The White Ribbon Alliance for Safe Motherhood today made public its challenge to world leaders gathered at the World Economic Forum on Africa to invest in women s health as necessary to save the lives of women needlessly lost in pregnancy and childbirth. Whil
- Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay: Now 100% Sensitive at Detecting CXCR4 HIV-1 Levels as Low as 0.3%
- PRNewswire - June 5, 2008
- SOUTH SAN FRANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) today announced immediate availability of enhanced sensitivity in its Trofile assay. Trofile was introduced commercially upon FDA approval of Selzentry(TM) (maraviroc), Pfizer s first in class CCR5 antagonist, in Augu
- Nation's High School Students Showing Overall Improvements in Health-Related Behaviors: However, Hispanic Students Not Showing Progress in Some Key Areas
- PRNewswire - June 4, 2008
- PRNewswire-USNewswire -- June 4/ Today s high school students are less likely to engage in many health risk behaviors than high school students in the early 1990s, according to the 2007 National Youth Risk Behavior Survey (YRBS), released today by the Centers for Disease Control and Prevention (CDC). Although the study
- Lymphoma Experts Herald 10 Years of the "Magic Bullet" -- Award and Lecture Mark Anniversary of Monoclonal Antibodies
- PRNewswire - June 4, 2008
- LUGANO, Switzerland , June 4/PRNewswire/ -- Today, physicians and patient group representatives from around the world celebrated the presentation of the San Salvatore Foundation award for outstanding achievement in the field of malignant lymphoma and the Henry Kaplan Memorial Lecture at the 10th International Conferenc
- Viacom to Receive Leadership Award for Business Excellence from The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria for Its 25 Years of Work on HIV/AIDS Education and Advocacy
- PRNewswire - June 4, 2008
- -- Viacom Executive Chairman Sumner M. Redstone to Accept Award At June 9 Event NEW YORK, June 4 /PRNewswire-FirstCall/ -- The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC) announced today that it will recognize Viacom (NYSE:VIA)(NYSE:and)(NYSE:VIA.B) with its prestigious Leadership Award for Bu
- Growing Generations Announces Surrogacy Program for Men with HIV
- PRNewswire - June 3, 2008
- LOS ANGELES, June 3 /PRNewswire/ -- Growing Generations, the nation s largest surrogacy agency, has launched a new program that provides surrogacy and egg donation services to men with HIV and allows them to use their own sperm to create biological families. The new program is made possible due to advances in technolog
- AdvanDx Submits Yeast Traffic Light PNA FISH(TM) for FDA 510(k) Clearance for Detection of Candida species in Positive Blood Cultures
- PRNewswire - June 3, 2008
- WOBURN, Mass., June 3 /PRNewswire/ -- AdvanDx today announced the FDA 510(k) submission of Yeast Traffic Light PNA FISH(TM) for detection of Candida yeast species from positive blood cultures. Yeast Traffic Light(TM) is the latest addition to AdvanDx s easy-to-use, molecular-based PNA FISH(TM) diagnostics platform that
- New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa
- PRNewswire - June 3, 2008
- -- More than 5 Million South Africans Living with HIV Gain Access to First and Only Co-formulated, Non-refrigerated Protease Inhibitor JOHANNESBURG, South Africa, June 3/PRNewswire/ -- Abbott (NYSE: ABT) today announced that the new tablet formulation of its protease inhibitor Aluvia(R) ( lopinavir
- NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998
- PRNewswire - June 3, 2008
- SAN MATEO, Calif., June 3 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (NASDAQ:NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced that it submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration for the clinical de
- New Publication of Phase 2 Data Shows Maribavir Markedly Reduced the Rate of Cytomegalovirus Infection and Disease in Bone Marrow Transplant Patients
- PRNewswire - June 2, 2008
- -- Prevalent in Immunosuppressed Patients, Cytomegalovirus Infection and Disease is Associated with a Range of Life Threatening Complications - EXTON, Pa., June 2 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) today announced the publication of results of its previously described Phase 2 study showing
- Driven By The Use of Premium-Priced Branded Agents, The HIV Drug Market Will Experience Robust Annual Growth Through 2012
- PRNewswire - June 2, 2008
- -- New Products From Novel Drug Classes Are Addressing Key Unmet Needs for Highly Treatment-Experienced Patients, According to a New Report from Decision Resources WALTHAM, Mass., June 2 /PRNewswire/ -- Decision Resources, one of the world s leading research and advisory firms for pharmaceutical and healthcare issues,
- Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care: Company's Report Entitled, 'Ingenuity at Work,' Discusses Abbott's Contributions to Access, Innovation, Science Education and the Environment
- PRNewswire - June 2, 2008
- ABBOTT PARK, Ill., June 2 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) today released its 2007 Global Citizenship Report, Ingenuity at Work, which is available online at http://www.abbott.com/citizenship. The report highlights Abbott s commitment to access to care, innovation, science education and the environment. N
- Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes
- PRNewswire - May 29, 2008
- WASHINGTON, May 29 /PRNewswire-USNewswire/ -- Three Miami area doctors and six others have been charged in four separate indictments for their roles in HIV infusion fraud schemes totaling $56 million, the Department of Justice Criminal Division and U.S. Attorney s Office for the Southern District of Florida announced t
- MyClyns(TM) Now Available in Single Units
- PRNewswire - May 29, 2008
- UNION, Ky., May 29 /PRNewswire/ -- Union Springs Pharmaceuticals, LLC, announced today it will now offer MyClyns in individually wrapped single units. These new packages provide enhanced tamper-proof protection for each MyClyns unit and also afford customers greater purchasing flexibility. Each sealed package will cont
- New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study: Study Demonstrated Efficacy of RELISTOR for Use in Advanced-Illness Patients with Opioid-Induced Constipation
- PRNewswire - May 28, 2008
- COLLEGEVILLE, Pa. and TARRYTOWN, N.Y., May 28 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) today announced the publication of results from a pivotal phase 3 trial of RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection in th
- Fact Sheet: Department of Justice Efforts to Combat Health Care Fraud and Abuse
- PRNewswire - May 28, 2008
- WASHINGTON, May 28 /PRNewswire-USNewswire/ -- The Department of Justice, in cooperation with the Department of Health and Human Services, has guided the enforcement efforts of the national Health Care Fraud and Abuse Control Program (HCFAC) since its inception in 1997. The program was designed to coordinate federal, st
- Caribbean People International Collective Inc to Host 8th Annual AIDS WALK CARIBBEAN
- PRNewswire - May 28, 2008
- BROOKLYN, N.Y., May 28 /PRNewswire-USNewswire/ -- Caribbean People International Collective Inc (CPIC) will host AIDS WALK CARIBBEAN (R) 2008. This 8th annual community event is set for Sunday, June 8th 2008--Caribbean American HIV/AIDS Awareness Day. The walk will begin with an opening sunrise ceremony at 9:30 A.M. an
- amfAR Appoints Dr. Annette Sohn as Vice President of Global Initiatives: Renowned pediatrician will lead AIDS research foundation's international program, including its TREAT Asia initiative
- PRNewswire - May 28, 2008
- NEW YORK, May 28 /PRNewswire-USNewswire/ -- amfAR, The Foundation for AIDS Research, has appointed Annette Sohn, MD, as vice president for global initiatives and director of TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia), announced Kevin Robert Frost, amfAR s chief executive officer. Dr. Sohn
- Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine
- PRNewswire - May 27, 2008
- WASHINGTON DC, May 27/PRNewswire-FirstCall/ -- Bavarian Nordic, the Danish-based biopharmaceutical company, has initiated a Phase I/II clinical study with its HIV vaccine candidate: MVA-BN(R) HIV multiantigen. Enrolment in a Phase I/II safety and immunogenicity study in 15 HIV-infected patients (CD4 counts >350 ul/ml)
- Successful Community-Driven Efforts Against HIV/AIDS Highlighted in Conference Panel
- PRNewswire - May 27, 2008
- -- Total Control of the Epidemic has reached Eight Million People in Africa and Asia WASHINGTON, May 27 /PRNewswire/ -- Only the People can Liberate Themselves from AIDS -- this is what reality has taught us and it represents the building block of our model to fight HIV & AIDS, says Marie Lichtenberg, Director of I
- 2,500 Riders in AIDS/LifeCycle Set to Leave San Francisco June 1, Bound for Los Angeles, Raising a Record $11+ Million for HIV/AIDS Services
- PRNewswire - May 27, 2008
- SAN FRANCISCO, May 27 /PRNewswire-USNewswire/ -- What: More than 2,500 cyclists and 500 volunteer roadies begin a 7-day, 545-mile bike ride to Los Angeles on Sunday, June 1. Participants in the 7th annual AIDS/LifeCycle will have raised more than $11 million for the San Francisco AIDS Foundation and L.A. Gay & Lesb
- Family Health International Featured at Global Health Council Conference
- PRNewswire - May 27, 2008
- RESEARCH TRIANGLE PARK, N.C., May 27 /PRNewswire-USNewswire/ -- Family Health International s staff will make several key presentations and the organization will introduce a number of new publications at the annual Global Health Council s International Conference May 27-31, 2008, at the Omni Shoreham Hotel in Washingto
- An Inspiring Summer Read: Biography of Judy Taylor - The Woman Who Could Not Eat
- PRNewswire - May 27, 2008
- TORONTO, May 27/PRNewswire/ -- With long summer days ahead and the delights of a good book to be enjoyed, readers around the world are picking up Lifeliner: The Judy Taylor story, the debut book from Shireen Jeejeebhoy. An inspiring summer read, it tells the poignant story of a young Canadian mother who made medical hi
- Africa day - great reasons to celebrate this Africa day!
- PRNewswire - May 25, 2008
- London, 25 May/GNN/ -- DEPARTMENT FOR INTERNATIONAL DEVELOPMENT News Release issued by The Government News Network on 25 May 2008 DFID MEDIA BRIEFING Every year, the African Union celebrates Africa Day. This year, people in the UK will join in the celebrations at the Mayor s event in Trafalgar Square on Monday 26th May
- Real Time, Face-to-Face Doctor Visits Now Available Online
- PRNewswire - May 23, 2008
- MIAMI, May 23 /PRNewswire/ -- MDWebLive.com, offering live video medical consultations via webcam between patients and board-certified doctors from multiple specialties has been launched in Miami by AmeriGroup Holdings, Inc. The service allows patients the opportunity to interact with their doctors from home, office, h
- Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program: Lead Candidate, RDEA806, Demonstrated No Reproductive Toxicity in Preclinical Study
- PRNewswire - May 22, 2008
- -- RDEA427 Selected as Clinical Candidate, Demonstrated a 40 Hour Half-Life with Potential for Once Daily Oral Dosing SAN DIEGO, May 22 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced preclinical data on its lead non-nucleoside reverse transcriptase inhibitor (NNRTI) candidate, RDEA806,
- Teens Traveling to Africa as Volunteers and Empowered Global Citizens: United Nations Association of the USA HERO Youth Ambassadors to volunteer in HIV/AIDS-affected communities in Africa
- PRNewswire - May 21, 2008
- NEW YORK, May 21 /PRNewswire-USNewswire/ -- HERO: a Campaign of the United Nations Association of the USA, with partners beinggirl.com and CosmoGIRL!, has announced its 2008 HERO Youth Ambassadors. This July, 22 American and Canadian high school and college students will travel to South Africa and
- HIV-AIDS and Women Equals Misogyny Finds On The Issues Magazine Online; New Computer Technology Makes Worldwide Accessibility
- PRNewswire - May 21, 2008
- NEW YORK, May 21 /PRNewswire-USNewswire/ -- HIV-AIDS is crossing the gender divide and targeting women while the world looks the other way. What is a woman worth? asks On The Issues Magazine Online in a series of probing articles and art that explore the deadly cocktail of sexism, silence and HIV. The feminization of H
- The Social Entrepreneur's Cup Awards Finalists Announced: Social Venture Partners Minnesota Announces Finalists for the 2008 Social Entrepreneur's Cup
- PRNewswire - May 21, 2008
- MINNEAPOLIS, May 21 /PRNewswire/ -- Social Venture Partners is proud to announce the five finalists for its Social Entrepreneur s Cup awards. The Social Entrepreneur s Cup is a first of its kind event in Minnesota in which five of Minnesota s most innovative and effective social entrepreneurs compete for recognition an
- BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
- PRNewswire - May 21, 2008
- JOHANNESBURG, South Africa , May 21 /PRNewswire/ -- BARC, a global central laboratory today announced a broad biobanking agreement to support HIV vaccine trials currently being performed in South Africa by the HIV Vaccine Trials Network (HVTN). The HVTN vaccine trials are designed to answer scientific questions that wi
- Speaker of the U.S. House of Representatives Nancy Pelosi Joins the Fight Against HIV/AIDS Stigma in A&PI Communities
- PRNewswire - May 21, 2008
- SAN FRANCISCO, May 21 /PRNewswire-USNewswire/ -- Speaker of the U.S. House of Representatives Nancy Pelosi appeals to Asian & Pacific Islanders (A&PI) to help end HIV stigma in their communities in the most recent Public Service Announcement (PSA) launched today by The Banyan Tree Project, a groundbreaking nati
- Quest Diagnostics Chooses Roche's Fully Automated, Real-Time HIV-1 Viral Load Monitoring Test For Its Customers in Laboratories Nationwide
- PRNewswire - May 19, 2008
- INDIANAPOLIS, May 19 /PRNewswire/ -- Roche Diagnostics today announced that Quest Diagnostics (NYSE:DGX), the nation s leading provider of diagnostic testing, information and services, has signed a multi-year agreement to use the COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HIV-1 Test for HIV viral load testing. Physicians
- Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
- PRNewswire - May 19, 2008
- -- Progenitor Cell Mobilization Observed in Subjects with Critical Limb Ischemia Treated with ZFP Therapeutic MIAMI, May 19 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced today the presentation of data from a Phase 1 clinical trial of a zinc finger DNA-binding protein activator of vascular
- Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C: IND or foreign regulatory equivalent filing anticipated in 1Q 2009
- PRNewswire - May 19, 2008
- PRINCETON, N.J., May 19 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) has nominated PSI-7851 as a lead development candidate for the treatment of chronic hepatitis C virus (HCV). PSI-7851 is a proprietary nucleotide analogue polymerase inhibitor of HCV that is being advanced into Good Laboratory Practice (GL
- Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
- PRNewswire - May 19, 2008
- -- RDEA594 Data to Be Presented at the 2008 Annual European Congress of Rheumatology Organized by the European League Against Rheumatism (EULAR) -- Initiation of Phase 1 Human Study of RDEA594 Planned in Second Half of 2008 SAN DIEGO, May 19 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announce
- Tuesday Congressional Briefing Relays Need for National AIDS Strategy
- PRNewswire - May 19, 2008
- WASHINGTON, May 19 /PRNewswire-USNewswire/ -- The following is being issued by AIDS Action: WHAT: Congressional Briefing It s Time to End the Epidemic at Home: The Need for a National AIDS Strategy WHEN: Tuesday, May 20, 2008 -- 1-2 p.m. (Lunch provided at 12:45 p.m.) WHERE: Rayburn Building, Room 2325 Honorary Con
- Tibotec Therapeutics Launches New Dosage Strength for PREZISTA(TM): New dosage strength reduces number of PREZISTA tablets taken daily
- PRNewswire - May 19, 2008
- BRIDGEWATER, N.J., May 19 /PRNewswire/ -- Tibotec Therapeutics today announced the availability of a new 600 mg tablet strength for PREZISTA(TM) (darunavir), a protease inhibitor (PI). The new dosage strength was approved by the U.S. Food and Drug Administration ( FDA ) on February 25, 2008. The recommended oral dose o
- Ronald Winston Retires From His Executive Role at Harry Winston Diamond Corporation, Named Honorary Chairman
- PRNewswire - May 19, 2008
- NEW YORK, May 19 /PRNewswire/ -- Ronald Winston announced his retirement today from his executive role at the world famous Harry Winston Inc., and his appointment as Honorary Chairman of the corporation. Mr. Winston is the son of the founder of the House of Harry Winston and has been the loyal steward of the brand sinc
- South Bay Asian and Pacific Islander Community Plans 'Express ARTself' for the 4th Annual National Asian & Pacific Islander HIV/AIDS Awareness Day
- PRNewswire - May 19, 2008
- SANTA CLARA, Calif., May 19 /PRNewswire-USNewswire/ -- FLARE Santa Clara HIV County Collaborative: PACE Clinic, Asian Americans for Community Involvement (AACI), The Billy DeFrank Center Lesbian and Gay Community Center, Song That Radio, Santa Clara County Public Health Department, Asian & Pacific Islander Wellness
- Banyan Tree Project Feature Asian & Pacific Islander Stars in Latest HIV/AIDS Anti-Stigma Public Service Announcements
- PRNewswire - May 19, 2008
- SAN FRANCISCO, May 19 /PRNewswire-USNewswire/ -- The Banyan Tree Project is helping put an end to HIV/AIDS-related stigma and discrimination. The program has released four 30-second public service announcements (PSAs) featuring three major Asian & Pacific Islander (A&PI) stars: Joan Chen, Amy Hanaiali i Gilliom
- World Hepatitis Alliance Calls on Governments to Take Urgent Action to Tackle Chronic Viral Hepatitis B & C Epidemic
- PRNewswire - May 19, 2008
- -- Shocking Lack of Global Statistics Prompts Creation of First Global Resource on Hepatitis: The Hepatitis Atlas GENEVA, Switzerland , May 19/PRNewswire/ -- The World Hepatitis Alliance, a newly formed Non-Governmental Organisation, today called on governments around the world to do more to drive improvements in preve
- PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C
- PRNewswire - May 18, 2008
- -- Largest prospective study in under-treated and under-studied population (The LATINO Study) provides important insights SAN DIEGO, Calif., May 18 /PRNewswire/ -- Roche today announced results from the LATINO study, the largest prospective study to evaluate the response of Latino whites infected with genotype 1 hepati
- AIDS Walk New York Raises $7.05 Million: World's Largest AIDS Fundraising Event Attracts 45,000 Participants and Raises Record Sum.
- PRNewswire - May 18, 2008
- -- Results Defy Economic Downturn and Remind Policy Makers that AIDS is Still a Crisis at Home NEW YORK, May 18 /PRNewswire-USNewswire/ -- The 23rd Annual AIDS Walk New York, on Sunday May 18, was the largest and most successful AIDS Walk ever held, setting a fundraising record even in the face of a troubled economy. O
- Body Positive Marks a New Era With Continued Commitment and a New Name: The Southwest Center for HIV/AIDS
- PRNewswire - May 18, 2008
- -- Arizona is Home to the Only HIV/AIDS Service Organization in the United States to Combine Research, Prevention/Education and Wellness Under one Roof PHOENIX, May 18 /PRNewswire/ -- In order to reflect its expanding reach and awareness, Body Positive christened its new name on Saturday, May 17, at Night for Life, t
- AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine
- PRNewswire - May 16, 2008
- -- Rebecca Haag s Statement for National HIV Vaccine Awareness Day, May 18 WASHINGTON, May 16 /PRNewswire-USNewswire/ -- Twenty-six years into the AIDS epidemic, someone is newly infected with HIV every 13 minutes in the U.S. On Sunday, May 18, HIV Vaccine Awareness Day, AIDS Action, one of five national partners in th
- World AIDS Vaccine Day 2008 - Debunking the Myth 25 Years Later: An AIDS Vaccine is Possible and Still Urgently Needed
- PRNewswire - May 16, 2008
- NEW YORK, May 16 /PRNewswire-USNewswire/ -- Twenty-five years since the discovery of HIV, the world has made considerable advances in addressing the AIDS pandemic. Scientists have learned a tremendous amount about HIV, perhaps more than any other pathogen, and have developed more drugs to treat AIDS than all other vira
- NeurogesX Reports First Quarter 2008 Results
- PRNewswire - May 15, 2008
- Highlights: - IND for liquid formulation, NGX-1998, expected to be opened and commencement of clinical development expected in second quarter of 2008 - NDA submission for dermal patch, NGX-4010, in PHN expected in second half of 2008 - NGX-4010 MAA under EMEA review for peripheral neuropathic pain
- Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
- PRNewswire - May 15, 2008
- PRINCETON, N.J., May 15 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, reported unaudited financial results for the second fiscal quarter ended March 31, 2008. Pharmasset re
- Immunizing Against Misinformation and Shortsightedness: AVAC Report Injects a Dose of Reality into the Debate on the State of AIDS Vaccine Research
- PRNewswire - May 15, 2008
- NEW YORK, May 15 /PRNewswire-USNewswire/ -- The AIDS Vaccine Advocacy Coalition (AVAC) today released a new report that provides a comprehensive review of recent developments in AIDS vaccine research. AVAC Report 2008: The Search Must Continue explores the issues that have been raised in the wake of the failure of Merc
- Golden Rainbow Takes a Musical Journey for Its 22nd Annual 'Ribbon of Life' Production Show: HIV/AIDS Fundraising Spectacular Takes Place June 14 & 15 at Paris Las Vegas
- PRNewswire - May 15, 2008
- LAS VEGAS, May 15 /PRNewswire/ -- It s an all-original, all-singing, all-dancing musical journey across America when Las Vegas-based HIV/AIDS charity Golden Rainbow presents its 22nd annual Ribbon of Life fundraising production show. The spectacular is staged June 14 and 15 in Le Theatre des Arts at Paris Las Vegas.
- Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
- PRNewswire - May 14, 2008
- -- Two 4-week cohorts will evaluate R7128 1000mg BID in HCV genotype 1 treatment-naive patients and R7128 1500mg BID in HCV genotypes 2 or 3 treatment-experienced patients PRINCETON, N.J., May 14 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) has commenced dosing two additional cohorts of a 4-week Phase 1 stu
- Hosting Summer's Sexiest Benefit, AIDS Service Center NYC Teams With Playboy Playmates, 'Project Runway' Stars, 'Naked Boys Singing'
- PRNewswire - May 14, 2008
- NEW YORK, May 14 /PRNewswire-USNewswire/ -- The following is an announcement by AIDS Service Center NYC of Safer Sex in the City, its much-anticipated annual benefit: WHEN: Thursday, June 19, 2008, 7:30pm-10:00pm VIP Cocktail Reception and performances, hosted by Bravo Project Runway stars Jack Mackenroth and Kevin Chr
- The Female Health Company Reports 267% Increase in Second Quarter Earnings: Diluted E.P.S. of $0.07 in First Half of FY2008
- PRNewswire - May 14, 2008
- Second quarter highlights: - 20% Revenue Increase - 31% Gross Profit Increase - 137% Operating Profit Increase - 267% Bottom line Improvement - Tax Benefit of $377 k adds 1 cent to E.P.S.
- Peregrine Pharmaceuticals Reports Studies Published in 'Science' Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
- PRNewswire - May 13, 2008
- -- Two New Studies Provide Further Evidence that PS Plays a Critical Role in Some Viral Infections -- Peregrine s Anti-PS Antibody Bavituximab is Currently Being Assessed in a Clinical Trial in HCV Patients Co-Infected with HIV TUSTIN, Calif., May 13 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPH
- TrimWater Makes it Fashionable to Care: Healthy Alternative Beverage joins forces with Jeffrey Fashion Cares to benefit AIDS Research
- PRNewswire - May 13, 2008
- NEW YORK, May 13 /PRNewswire/ -- TrimWater has announced a partnership with Jeffrey Kalinsky, of the Jeffrey high-fashion stores in NY and Atlanta, to support the fundraising efforts of the Jeffrey Fashion Cares non-profit organization. TrimWater was present as a sponsor for this year s Fashion Cares event in NYC Chair
- Tuesday, May 13th Is the Latino Commission on AIDS' Annual Gala Cielo Latino 2008 - Unidos Podemos Cielo Latino To Honor Advocates of HIV/AIDS
- PRNewswire - May 13, 2008
- WHO: The Latino Commission on AIDS honors four distinguished individuals during the 13th annual Cielo Latino benefit and pays tribute to the life of its leader, Dennis deLeon, who has been living with HIV for 20 years. -- Bill Roedy, MTV International, Business Leadership Award -- Arisa Batista-Cunningham,
- U.S. Global AIDS Coordinator to Present President's Emergency Plan for AIDS Relief to San Francisco Doctors on May 14th
- PRNewswire - May 12, 2008
- Ambassador Mark Dybul, MD, U.S. Global AIDS Coordinator, will be in San Francisco on May 14, 2008, to discuss the President s Emergency Plan for AIDS Relief (PEPFAR) with the leadership of the San Francisco Medical Society (SFMS). The group will meet for lunch at noon at California Pacific Medical Center (CPMC) and mem
- GeoVax Secures $10 Million Financing Commitment
- PRNewswire - May 12, 2008
- ATLANTA, May 12 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta- based HIV/AIDS vaccine development company, announced today that it has entered into a $10 million common stock purchase agreement with Fusion Capital Fund II, LLC, a Chicago-based institutional investor. The Company may se
- Napo Presents at ISPOR Meeting in Toronto
- PRNewswire - May 12, 2008
- SOUTH SAN FRANCISCO, Calif., May 12 /PRNewswire-FirstCall/ -- Napo Pharmaceuticals, Inc., , announces that it presented a poster in collaboration with QualityMetric, Inc. describing the development of a patient reported outcomes questionnaire focused on the Health-Related Quality of Life (HR-QoL) aspects of chronic dia
- Starpharma Reports Positive VivaGel(R) Clinical Study Results
- PRNewswire - May 12, 2008
- MELBOURNE, Australia , May 12/PRNewswire/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced positive results of a clinical trial that achieved all its objectives demonstrating that 3% SPL7013 Gel (VivaGel(R)) was safe and well-tolerated in sexually abstinent women when administered vaginally, twic
- 'Miles From Home' Market Debut at the 2008 Cannes Film Festival
- PRNewswire - May 9, 2008
- -- Official Screening to Take Place May 21st at 5:30pm at the Palais Theater J LOS ANGELES, May 9 /PRNewswire/ -- Miles from Home, a film, produced by writer/director, Ty Hodges, cinematographer/editor Todd Segal, Meagan Good and Marlon Ollivierre, will make its international debut at the 2008 Marche du Film Festival i
- Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
- PRNewswire - May 9, 2008
- SAN DIEGO, May 9 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA), a company focused on the discovery and development of small- molecule therapeutics for the treatment of HIV, cancer and inflammatory diseases, including gout, today announced that John W. Beck has been appointed Senior Vice President, Fin
- AIDS.gov Goes 2.0: Government HIV/AIDS Website Now Features a Blog, Podcasts, and More
- PRNewswire - May 7, 2008
- WASHINGTON, May 7 /PRNewswire-USNewswire/ -- The HHS Office of HIV/AIDS Policy announced today that the Web site AIDS.gov, a gateway to all federal domestic HIV /AIDS information and resources, now has an innovative look and feel that incorporates a blog, podcasts, and other new media tools. The blog (http://blog.aids.
- Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug
- PRNewswire - May 7, 2008
- TORONTO, May 7 /PRNewswire/ -- Apotex Inc., Canada s largest generic pharmaceutical company has successfully bid and been awarded a tender from the Rwandan Government for the life saving triple combination AIDS drug Apo Triavir . Apotex is the first company to provide this medicine to Africa under the provisions of the
- Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay
- PRNewswire - May 7, 2008
- -- SensiTrop II accurately classifies Dual/Mixed tropic HIV patients with samples provided by Pfizer MALIBU, Calif., May 7 /PRNewswire/ -- Pathway Diagnostics announces nationwide availability of its patented second generation molecular SensiTrop(TM) II assay, combining the sensitivity of molecular heteroduplex trackin
- USAID and British Work to Improve Sexual Health
- PRNewswire - May 6, 2008
- PHNOM PENH, Cambodia , May 6 /PRNewswire-USNewswire/ -- A new program aimed at reducing the rate of new HIV infections and child mortality and improving reproductive and sexual health for Cambodians begins May 6 thanks to the joint efforts of the U.S. Agency for International Development and the British Department for
- 46664 Concert Honouring Nelson Mandela at 90; A Gathering of 46,664 Great Friends and Supporters; London, Hyde Park, June 27, 2008
- PRNewswire - May 6, 2008
- -- Presale tickets at http://www.46664.com | Tickets on public sale Friday, May 9 at http://www.livenation.co.uk LONDON, May 6 /PRNewswire/ -- Many of the world s most powerful and instantly recognisable figures and a concert audience of 46,664 will pay their tributes to one of the world s most loved leaders, Nobel Pea
- Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
- PRNewswire - May 5, 2008
- SWARTZ CREEK, Mich., May 5 /PRNewswire/ -- Diplomat Specialty Pharmacy announced today that their proprietary and exclusive Electronic Navigator (eNAV(TM)) patient care system is now live and being utilized to manage their multiple sclerosis patients. The company plans to use eNAV(TM) as a disease management tool for a
- This Mother's Day, Surprise Mom With a New Way to Give: From baby chicks to gardens, Oxfam America Unwrapped offers unique gifts for Mom
- PRNewswire - May 5, 2008
- BOSTON, May 5 /PRNewswire-USNewswire/ -- Year after year, gift-givers are faced with the same dilemma: What to get mom? From flowers to macaroni necklaces, she always loves a gift that comes from you on Mother s Day. This year, Oxfam America Unwrapped provides a unique way to give the perfect gift and make a difference
- Mothers and Offspring Can Share Cells Throughout Life
- PRNewswire - May 2, 2008
- SEATTLE, May 2 /PRNewswire-USNewswire/ -- Cutting the umbilical cord doesn t necessarily sever the physical link between mother and child. Many cells pass back and forth between the mother and fetus during pregnancy and can be detected in the tissues and organs of both even decades later. This mixing of cells from two
- Largest Ever Regional AIDS Conference to Review Epidemic Status and Changing Challenges in the Response
- PRNewswire - May 2, 2008
- -- Broadest range of public and non-governmental sector participants ever to address the changing face of HIV in the region and the critical crossroad the response faces MOSCOW, May 2 /PRNewswire/ -- Starting tomorrow, the second Eastern Europe and Central Asia AIDS Conference (EECAAC II), the largest AIDS-focused even
- Black Enterprise Unveils America's Leading Doctors: May 2008 Special Report Highlights 140 Doctors Changing the Face of Medicine
- PRNewswire - May 1, 2008
- NEW YORK, May 1 /PRNewswire/ -- The May issue of BLACK ENTERPRISE (BE) unveils its 2008 report on the best and brightest in medicine. In America s Leading Doctors, BE names 140 top-notch physicians responsible for saving millions of lives through the revolutionary treatment of diseases, from cancer and diabetes to hear
- Monogram Announces 2008 First Quarter Financial Results
- PRNewswire - May 1, 2008
- 57% Revenue Growth; New VeraTag Assays Available for Clinical Development - Conference call tod